Welcome to the Division of Pediatric Hematology/Oncology
Providing innovative patient care by:
- Originating and translating discoveries to cure childhood cancer and blood diseases
- Enhancing the lives of children with cancer or blood diseases, from birth to adulthood
- Delivering superior outcomes through trans-disciplinary care
- Training the next generations of leaders
Our fellowship program is designed to train the next generation of leaders in the field. Clinical care is delivered in state-of-the art facilities within Stanford Children's Health | Lucile Packard Children's Hospital at Stanford. Research laboratories are located at Stanford University School of Medicine. Our location on the campus of Stanford University provides an unparalleled opportunity for collaborative, cross-disciplinary research to further the mission of the Division. Clinical care for our patients is delivered in the Bass Center for Childhood Cancer and Blood Disorders.
Sheri Spunt, MD, MBA
Professor and Division Chief
Co-Director of Bass Center for Childhood
Cancer and Blood Disorders
Sheri Spunt, MD, MBA
Dr. Spunt is a Professor of Pediatrics and in 2013 was recruited to Stanford University from St. Jude Children’s Research Hospital where she was Deputy Clinical Director of the hospital. Her clinical and research interests have focused on the treatment and biology of soft tissue sarcomas, an area where she is an internationally recognized expert. She serves on multiple committees of the Children’s Oncology Group and is Vice-Chair of its Soft Tissue Sarcoma Committee. In addition to being Division Chief of Hematology/Oncology she is co-Director of the Bass Childhood Cancer Center in the Lucile Packard Children's Hospital at Stanford.
Tumor suppressor also inhibits key property of stem cells, researchers say
Stanford University Investigators Awarded Grant for Children's Cancer Research
CureSearch for Children's Cancer this week awarded Kathleen Sakamoto, MD, PhD, and Irv Weissman, MD, of the Stanford University School of Medicine a $1.37 million grant to research the effects of an antibody known to help a patient's immune system rid the body of cancer cells. If successful, their work will lead to a new approach to treat childhood cancer and improve both the overall survival and quality of life for children with cancer.